desmoid tumors: the nonmalignant malignancy · r. lor randall md, facs ... schwartz hs, tap wd,...
TRANSCRIPT
![Page 1: Desmoid Tumors: The Nonmalignant Malignancy · R. Lor Randall MD, FACS ... Schwartz HS, Tap WD, Wayne JD, Bergman MA, Scavone J. Soft Tissue Sarcoma, Version 2.2016, ... •Kasper](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fd5e70b2dc6b36ff82d0c2a/html5/thumbnails/1.jpg)
HCI Sarcoma Services
Desmoid Tumors:The Nonmalignant Malignancy
R. Lor Randall MD, FACSThe L.B. and Olive S. Young Presidential Chair for Cancer Research
Director, Sarcoma Services & SARC Fellowship, LabMedical Director, HCH Surgical Services
Co-Leader Sarcoma Disease Oriented Research TeamCo-Director, Huntsman-Intermountain Adolescent & Young Adult Cancer Care Program
Huntsman Cancer Institute & Primary Children’s HospitalUniversity of Utah
Sara Shaw, BS
John Groundland, MDDTRF Western Region Meeting
April 28, 2017
SLC, UT
![Page 2: Desmoid Tumors: The Nonmalignant Malignancy · R. Lor Randall MD, FACS ... Schwartz HS, Tap WD, Wayne JD, Bergman MA, Scavone J. Soft Tissue Sarcoma, Version 2.2016, ... •Kasper](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fd5e70b2dc6b36ff82d0c2a/html5/thumbnails/2.jpg)
![Page 3: Desmoid Tumors: The Nonmalignant Malignancy · R. Lor Randall MD, FACS ... Schwartz HS, Tap WD, Wayne JD, Bergman MA, Scavone J. Soft Tissue Sarcoma, Version 2.2016, ... •Kasper](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fd5e70b2dc6b36ff82d0c2a/html5/thumbnails/3.jpg)
Disclosures• DTRF
• Zimmer Biomet
• Daiichi Sankyo
• Chair, Orthopaedics, Children’s Oncology Group
• Vice Chair, Bone Cmte, Children’s Oncology Group
• Steering Cmte, Soft Tissue Sarcoma, COG
• Sarcoma Foundation of America, Medical Advisory Board
• Past President, Connective Tissue Oncology Society
• President-Elect, Musculoskeletal Tumor Society
• President-Elect, ABJS
• Co-Chair NCCN ST Sarcoma Cmte
• The University of Utah is MTF Institution
• Past recipient DTRF
• Editor, various journals
![Page 4: Desmoid Tumors: The Nonmalignant Malignancy · R. Lor Randall MD, FACS ... Schwartz HS, Tap WD, Wayne JD, Bergman MA, Scavone J. Soft Tissue Sarcoma, Version 2.2016, ... •Kasper](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fd5e70b2dc6b36ff82d0c2a/html5/thumbnails/4.jpg)
Desmoid Tumor – What Is It?
• Benign soft tissue tumor
– Derived from mesenchymal (connective) tissue
– Driven most commonly by a genetic aberration
involving the beta–catenin or APC gene
• No metastatic potential
• Can be locally aggressive, painful, and
potentially morbid
– Locally “malignant”
– Can malign one’s life
![Page 5: Desmoid Tumors: The Nonmalignant Malignancy · R. Lor Randall MD, FACS ... Schwartz HS, Tap WD, Wayne JD, Bergman MA, Scavone J. Soft Tissue Sarcoma, Version 2.2016, ... •Kasper](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fd5e70b2dc6b36ff82d0c2a/html5/thumbnails/5.jpg)
Tumors Derived from Fibrous Tissue
• Fibromas
• Fibromatosis – dupytren / lederhosen
• Nodular Fasciitis
• Desmoid Tumors
• Dermatofibrosarcoma Protuberans
• Fibrosarcoma
![Page 6: Desmoid Tumors: The Nonmalignant Malignancy · R. Lor Randall MD, FACS ... Schwartz HS, Tap WD, Wayne JD, Bergman MA, Scavone J. Soft Tissue Sarcoma, Version 2.2016, ... •Kasper](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fd5e70b2dc6b36ff82d0c2a/html5/thumbnails/6.jpg)
Desmoid Tumor – Classification
Desmoid Tumors
![Page 7: Desmoid Tumors: The Nonmalignant Malignancy · R. Lor Randall MD, FACS ... Schwartz HS, Tap WD, Wayne JD, Bergman MA, Scavone J. Soft Tissue Sarcoma, Version 2.2016, ... •Kasper](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fd5e70b2dc6b36ff82d0c2a/html5/thumbnails/7.jpg)
Desmoid Tumors – What Do They Do?
Concise, accurate description of behavior
is difficult to make, due to their:
• Low incidence
• Variable anatomic locations
• Wide spectrum of locally aggressive
behavior
![Page 8: Desmoid Tumors: The Nonmalignant Malignancy · R. Lor Randall MD, FACS ... Schwartz HS, Tap WD, Wayne JD, Bergman MA, Scavone J. Soft Tissue Sarcoma, Version 2.2016, ... •Kasper](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fd5e70b2dc6b36ff82d0c2a/html5/thumbnails/8.jpg)
Desmoid Tumor
Two Clinical Entities1. Sporadic
85% of desmoid cases
More commonly occur in the extremities
Beta-Catenin gene mutation
2. Familial Adenomatous Polyposis (FAP)
15% of desmoid cases
FAP desmoids are usually in the abdomen
APC gene mutation
People with FAP have 1000x higher incidence of
desmoid than the general population
![Page 9: Desmoid Tumors: The Nonmalignant Malignancy · R. Lor Randall MD, FACS ... Schwartz HS, Tap WD, Wayne JD, Bergman MA, Scavone J. Soft Tissue Sarcoma, Version 2.2016, ... •Kasper](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fd5e70b2dc6b36ff82d0c2a/html5/thumbnails/9.jpg)
Desmoid Tumor – Presentation
Highly variable because of the highly
variable nature of the tumor itself:
– Size
– Location
– Rate of growth and/or infiltration
![Page 10: Desmoid Tumors: The Nonmalignant Malignancy · R. Lor Randall MD, FACS ... Schwartz HS, Tap WD, Wayne JD, Bergman MA, Scavone J. Soft Tissue Sarcoma, Version 2.2016, ... •Kasper](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fd5e70b2dc6b36ff82d0c2a/html5/thumbnails/10.jpg)
Desmoid Tumor – Presentation
• A Bump
• Growth may be slow or rapid
• Pain may occur, from local nerve compression or rapid
growth causing swelling
• Depending on location of tumor, neighboring anatomic
structures may become compressed
– Neck airway or vascular obstruction shortness
of breath or lightheadedness
– Extremity nerve compression numbness,
tingling, weakness
– Abdominal nausea, bowel obstruction
![Page 11: Desmoid Tumors: The Nonmalignant Malignancy · R. Lor Randall MD, FACS ... Schwartz HS, Tap WD, Wayne JD, Bergman MA, Scavone J. Soft Tissue Sarcoma, Version 2.2016, ... •Kasper](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fd5e70b2dc6b36ff82d0c2a/html5/thumbnails/11.jpg)
Desmoid Tumor – The Numbers
• New Cases diagnosed/year in the US:900
• Age– Range:any
– Most common: 30-50 years
• Gender– 2:1 female:male
– Hormone sensitivity?• Higher prevalence in females
• Growth often changes with pregnancy, menopause and oral contraceptive
![Page 12: Desmoid Tumors: The Nonmalignant Malignancy · R. Lor Randall MD, FACS ... Schwartz HS, Tap WD, Wayne JD, Bergman MA, Scavone J. Soft Tissue Sarcoma, Version 2.2016, ... •Kasper](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fd5e70b2dc6b36ff82d0c2a/html5/thumbnails/12.jpg)
Desmoid Tumor – Anatomic Locations
• Extra-Abdominal – Usually Sporadic Cases
– 50% Limbs
– 43% Trunk
– 7% Head and Neck
– 10% have multi-focal presentation
• Intra-abdominal – Usually associated with FAP
– Patients with an intra-abdominal desmoid
should be screened with colonoscopy
Merchant et al, Cancer 1999
![Page 13: Desmoid Tumors: The Nonmalignant Malignancy · R. Lor Randall MD, FACS ... Schwartz HS, Tap WD, Wayne JD, Bergman MA, Scavone J. Soft Tissue Sarcoma, Version 2.2016, ... •Kasper](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fd5e70b2dc6b36ff82d0c2a/html5/thumbnails/13.jpg)
Desmoid Tumor – Evaluation
• History and Physical
• Imaging
• Biopsy
• Team Approach
Goal:
Establish the diagnosis
and develop a comprehensive plan of care
NCCN Clinical Practice Guidelines in Oncology, 2017
![Page 14: Desmoid Tumors: The Nonmalignant Malignancy · R. Lor Randall MD, FACS ... Schwartz HS, Tap WD, Wayne JD, Bergman MA, Scavone J. Soft Tissue Sarcoma, Version 2.2016, ... •Kasper](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fd5e70b2dc6b36ff82d0c2a/html5/thumbnails/14.jpg)
Desmoid Tumor – Evaluation
• History and Physical
– History of the mass• First appearance
• Rate of growth
– Local symptoms
– Systemic symptoms
– Physical nature of the mass: mobile, firm …
• Imaging
• Biopsy
• Team Approach
![Page 15: Desmoid Tumors: The Nonmalignant Malignancy · R. Lor Randall MD, FACS ... Schwartz HS, Tap WD, Wayne JD, Bergman MA, Scavone J. Soft Tissue Sarcoma, Version 2.2016, ... •Kasper](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fd5e70b2dc6b36ff82d0c2a/html5/thumbnails/15.jpg)
Desmoid Tumor – Evaluation
• History and Physical
• Imaging
– Ultrasound
– Radiographs
– MRI
– CT
• Biopsy
• Team Approach
![Page 16: Desmoid Tumors: The Nonmalignant Malignancy · R. Lor Randall MD, FACS ... Schwartz HS, Tap WD, Wayne JD, Bergman MA, Scavone J. Soft Tissue Sarcoma, Version 2.2016, ... •Kasper](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fd5e70b2dc6b36ff82d0c2a/html5/thumbnails/16.jpg)
ExamplesMRI of a 26 year old female with a
desmoid tumor in the gluteal musculature
![Page 17: Desmoid Tumors: The Nonmalignant Malignancy · R. Lor Randall MD, FACS ... Schwartz HS, Tap WD, Wayne JD, Bergman MA, Scavone J. Soft Tissue Sarcoma, Version 2.2016, ... •Kasper](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fd5e70b2dc6b36ff82d0c2a/html5/thumbnails/17.jpg)
ExamplesMRI of a 40 year old female with a
superficial desmoid tumor of the flank
![Page 18: Desmoid Tumors: The Nonmalignant Malignancy · R. Lor Randall MD, FACS ... Schwartz HS, Tap WD, Wayne JD, Bergman MA, Scavone J. Soft Tissue Sarcoma, Version 2.2016, ... •Kasper](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fd5e70b2dc6b36ff82d0c2a/html5/thumbnails/18.jpg)
ExamplesMRI of a 27 year old female with desmoid
tumor of the left leg
Radiograph Ultrasound MRI
![Page 19: Desmoid Tumors: The Nonmalignant Malignancy · R. Lor Randall MD, FACS ... Schwartz HS, Tap WD, Wayne JD, Bergman MA, Scavone J. Soft Tissue Sarcoma, Version 2.2016, ... •Kasper](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fd5e70b2dc6b36ff82d0c2a/html5/thumbnails/19.jpg)
ExamplesMRI of a 46 year old female with
desmoid tumor of the right arm
![Page 20: Desmoid Tumors: The Nonmalignant Malignancy · R. Lor Randall MD, FACS ... Schwartz HS, Tap WD, Wayne JD, Bergman MA, Scavone J. Soft Tissue Sarcoma, Version 2.2016, ... •Kasper](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fd5e70b2dc6b36ff82d0c2a/html5/thumbnails/20.jpg)
Desmoid Tumor – Evaluation
• History and Physical
• Imaging
• Biopsy
– Image-guided
– Open
• Team Approach
![Page 21: Desmoid Tumors: The Nonmalignant Malignancy · R. Lor Randall MD, FACS ... Schwartz HS, Tap WD, Wayne JD, Bergman MA, Scavone J. Soft Tissue Sarcoma, Version 2.2016, ... •Kasper](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fd5e70b2dc6b36ff82d0c2a/html5/thumbnails/21.jpg)
Desmoid Tumor – Evaluation
• History and Physical
• Imaging
• Biopsy
• Team Approach
– Orthopedic and General Oncologic Surgeons
– Medical Oncologist
– Radiation Oncologist
– Musculoskeletal Radiologist
– Pathologist
![Page 22: Desmoid Tumors: The Nonmalignant Malignancy · R. Lor Randall MD, FACS ... Schwartz HS, Tap WD, Wayne JD, Bergman MA, Scavone J. Soft Tissue Sarcoma, Version 2.2016, ... •Kasper](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fd5e70b2dc6b36ff82d0c2a/html5/thumbnails/22.jpg)
Desmoid Tumor
What Should We Do?
• Watch
• Medication
• Surgery
• Radiation
![Page 23: Desmoid Tumors: The Nonmalignant Malignancy · R. Lor Randall MD, FACS ... Schwartz HS, Tap WD, Wayne JD, Bergman MA, Scavone J. Soft Tissue Sarcoma, Version 2.2016, ... •Kasper](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fd5e70b2dc6b36ff82d0c2a/html5/thumbnails/23.jpg)
Desmoid Tumor – Treatment
• Watching ≠ Doing nothing
• Spontaneous Regression vs Disease stabilization vs
Progression
• Spontaneous regression occurs in up to 50% of cases
• If regression occurs, average time to regression is 32
months
• Conversion to active treatment occurs in up to 50% of
cases; as long as surveillance is adequate, no “bridges
are burnt.”
Watch Medicine Surgery Radiation
Kasper et al, European Journal of Cancer, 21015
Park et al, Journal of Surgical Research, 2016
![Page 24: Desmoid Tumors: The Nonmalignant Malignancy · R. Lor Randall MD, FACS ... Schwartz HS, Tap WD, Wayne JD, Bergman MA, Scavone J. Soft Tissue Sarcoma, Version 2.2016, ... •Kasper](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fd5e70b2dc6b36ff82d0c2a/html5/thumbnails/24.jpg)
• Will a Desmoid Progress?
– Studies are contradictory
– No single factor or genetic aberration has been identified to
clearly predict behavior
• Potential Predictors of Progression
– Female gender
– Younger age at presentation (under 30-35)
– Larger tumor size (>5-10 cm)
– Anatomic location (extremity desmoids, particularly in
hands / feet)
Watch Medicine Surgery Radiation
Desmoid Tumor – Treatment
![Page 25: Desmoid Tumors: The Nonmalignant Malignancy · R. Lor Randall MD, FACS ... Schwartz HS, Tap WD, Wayne JD, Bergman MA, Scavone J. Soft Tissue Sarcoma, Version 2.2016, ... •Kasper](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fd5e70b2dc6b36ff82d0c2a/html5/thumbnails/25.jpg)
Many Medicine Options:
• NSAIDs
• Anti-estrogens &
aromatase inhibitors
• Chemotherapy
• Targeted therapy
• Combination Therapy
Watch Medicine Surgery Radiation
Desmoid Tumor – Treatment
![Page 26: Desmoid Tumors: The Nonmalignant Malignancy · R. Lor Randall MD, FACS ... Schwartz HS, Tap WD, Wayne JD, Bergman MA, Scavone J. Soft Tissue Sarcoma, Version 2.2016, ... •Kasper](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fd5e70b2dc6b36ff82d0c2a/html5/thumbnails/26.jpg)
Definitive and comparative response rates
between medications are not available due
to the small number of patients studied,
variable application of medications and wide
range of tumor characteristics studied.
Watch Medicine Surgery Radiation
Desmoid Tumor – Treatment
![Page 27: Desmoid Tumors: The Nonmalignant Malignancy · R. Lor Randall MD, FACS ... Schwartz HS, Tap WD, Wayne JD, Bergman MA, Scavone J. Soft Tissue Sarcoma, Version 2.2016, ... •Kasper](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fd5e70b2dc6b36ff82d0c2a/html5/thumbnails/27.jpg)
Watch Medicine Surgery Radiation
Desmoid Tumor – Treatment
Bocale et al, Colorectal Disease 2011. Constantinidou et al Acta Oncologica, 2011
Fiore et al, European Journal of Cancer, 2015. Quast et al, Fam Onc 2016
![Page 28: Desmoid Tumors: The Nonmalignant Malignancy · R. Lor Randall MD, FACS ... Schwartz HS, Tap WD, Wayne JD, Bergman MA, Scavone J. Soft Tissue Sarcoma, Version 2.2016, ... •Kasper](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fd5e70b2dc6b36ff82d0c2a/html5/thumbnails/28.jpg)
• Once considered the cornerstone of
treatment, surgery is now reserved for a
limited subset of tumors
• Reports on the rate of relapse following
surgical resection vary
– Influenced by tumor characteristics and
ability to excise the entirety of the tumor
Watch Medicine Surgery Radiation
Desmoid Tumor – Treatment
Melis et al, JCO, 2008
![Page 29: Desmoid Tumors: The Nonmalignant Malignancy · R. Lor Randall MD, FACS ... Schwartz HS, Tap WD, Wayne JD, Bergman MA, Scavone J. Soft Tissue Sarcoma, Version 2.2016, ... •Kasper](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fd5e70b2dc6b36ff82d0c2a/html5/thumbnails/29.jpg)
Study “Clean” Surgical
Margins
Microscopic (+)
Margins
Macroscopic (+)
Margins
Spear et al 23% 44% 50%
Posner et al 15% 55%
Merchant et al 24% 22% 50%
Gronchi et al 23% 26%
Watch Medicine Surgery Radiation
Recurrence rate after surgery based on extent
of residual demonstrable disease
Desmoid Tumor – Treatment
![Page 30: Desmoid Tumors: The Nonmalignant Malignancy · R. Lor Randall MD, FACS ... Schwartz HS, Tap WD, Wayne JD, Bergman MA, Scavone J. Soft Tissue Sarcoma, Version 2.2016, ... •Kasper](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fd5e70b2dc6b36ff82d0c2a/html5/thumbnails/30.jpg)
• Radiation can be used alone or as an
adjunct to surgery
• Isolated radiation can control disease
progression in 78% of cases
• Radiation following surgery has produced
contradictory results
• Doses of 50-60 Gy are required
– Can have unwanted side effects / risks,
particularly in young patients with decades of life
remaining
Watch Medicine Surgery Radiation
Desmoid Tumor – Treatment
Miralbell et al, Int J of Rad Onc Bio Phys, 1990
![Page 31: Desmoid Tumors: The Nonmalignant Malignancy · R. Lor Randall MD, FACS ... Schwartz HS, Tap WD, Wayne JD, Bergman MA, Scavone J. Soft Tissue Sarcoma, Version 2.2016, ... •Kasper](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fd5e70b2dc6b36ff82d0c2a/html5/thumbnails/31.jpg)
MRI guided Ultrasound Ablation•MRI is used to determine the depth / width of the tumor, allowing
ultrasound to be focused on the tumor, sparing neighboring tissues.
•Ultrasound increases micromotion within the tissue, resulting in a
focused increase in energy – which manifests as heat
•Heating of the desmoid to 50-80 degrees C may cause tissue death
•Early reports (18 total patients) have demonstrated the ability of this
ablation to reduce both total tumor volume and viable tumor volume
•In the report by Ghanouni, Tumor Volume decreased 39 -100%, but
follow up was limited (5-39 months) due novelty of the technique
Watch Medicine Surgery Radiation
Desmoid Tumor - EmergingTreatment
Bucknor MD, Rieke V. J Ther Ultrasound. 2017
Ghanouni et al Eur Radiol. 2017
![Page 32: Desmoid Tumors: The Nonmalignant Malignancy · R. Lor Randall MD, FACS ... Schwartz HS, Tap WD, Wayne JD, Bergman MA, Scavone J. Soft Tissue Sarcoma, Version 2.2016, ... •Kasper](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fd5e70b2dc6b36ff82d0c2a/html5/thumbnails/32.jpg)
Diagnosis
Evaluation by a
Multi-disciplinary
team
Radiation
Alone for
unresectable
disease or
Adjuvant to surgery
Surgery
Symptomatic
and/or
resectable
disease
Medication
NSAIDs
Hormones
Targeted Rx
Chemotherapy
Watchful
Waiting
Repeat Exam
Repeat
Imaging
Desmoid Tumor
A Multi-Disciplinary Approach
Ablation
Emerging
technique for
appropriate cases
![Page 33: Desmoid Tumors: The Nonmalignant Malignancy · R. Lor Randall MD, FACS ... Schwartz HS, Tap WD, Wayne JD, Bergman MA, Scavone J. Soft Tissue Sarcoma, Version 2.2016, ... •Kasper](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fd5e70b2dc6b36ff82d0c2a/html5/thumbnails/33.jpg)
Additional References
Review Articles and General Clinical Guidelines
•Eastley N, McCulloch T, Esler C, Hennig I, Fairbairn J, Gronchi A, Ashford R. Extra-abdominal desmoid
fibromatosis: A review of management, current guidance and unanswered questions. Eur J Surg Oncol.
2016 Jul;42(7):1071-83.
•Hawkins DS, Spunt SL, Skapek SX; COG Soft Tissue Sarcoma Committee. Children's Oncology
Group's 2013 blueprint for research: Soft tissue sarcomas. Pediatr Blood Cancer. 2013 Jun;60(6):1001-
8.
•von Mehren M, Randall RL, Benjamin RS, Boles S, Bui MM, Conrad EU 3rd, Ganjoo KN, George S,
Gonzalez RJ, Heslin MJ, Kane JM 3rd, Koon H, Mayerson J, McCarter M, McGarry SV, Meyer C,
O'Donnell RJ, Pappo AS, Paz IB, Petersen IA, Pfeifer JD, Riedel RF, Schuetze S, Schupak KD,
Schwartz HS, Tap WD, Wayne JD, Bergman MA, Scavone J. Soft Tissue Sarcoma, Version 2.2016,
NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2016 Jun;14(6):758-86.
Desmoid Tumor and Familial Adenomatous Polyposis
•Turina M, Pavlik CM, Heinimann K, Behrensmeier F, Simmen HP. Recurrent desmoids determine
outcome in patients with Gardner syndrome: a cohort study of three generations of an APC mutation-
positive family across 30 years. Int J Colorectal Dis. 2013 Jun;28(6):865-72.
•Calvert GT, Monument MJ, Burt RW, Jones KB, Randall RL. Extra-abdominal desmoid tumors
associated with familial adenomatous polyposis. Sarcoma. 2012;2012:726537
![Page 34: Desmoid Tumors: The Nonmalignant Malignancy · R. Lor Randall MD, FACS ... Schwartz HS, Tap WD, Wayne JD, Bergman MA, Scavone J. Soft Tissue Sarcoma, Version 2.2016, ... •Kasper](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fd5e70b2dc6b36ff82d0c2a/html5/thumbnails/34.jpg)
Studies Investigating Desmoid Response to Medicine•Chugh R, Wathen JK, Patel SR, Maki RG, Meyers PA, Schuetze SM, Priebat DA, Thomas DG, Jacobson JA, Samuels
BL, Benjamin RS, Baker LH; Sarcoma Alliance for Research through Collaboration (SARC). Efficacy of imatinib in
aggressive fibromatosis: Results of a phase II multicenter Sarcoma Alliance for Research through Collaboration (SARC)
trial. Clin Cancer Res. 2010 Oct 1;16(19):4884-9
•Dufresne A, Bertucci F, Penel N, Le Cesne A, Bui B, Tubiana-Hulin M, Ray-Coquard I, Cupissol D, Chevreau C, Perol
D, Goncalves A, Jimenez M, Bringuier PP, Blay JY. Identification of biological factors predictive of response to imatinib
mesylate in aggressive fibromatosis. Br J Cancer. 2010 Aug 10;103(4):482-5.
•Kasper B, Gruenwald V, Reichardt P, Bauer S, Rauch G, Limprecht R, Sommer M, Dimitrakopoulou-Strauss A, Pilz L,
Haller F, Hohenberger P. Imatinib induces sustained progression arrest in RECIST progressive desmoid tumours: Final
results of a phase II study of the German Interdisciplinary Sarcoma Group (GISG). Eur J Cancer. 2017 May;76:60-67.
•Kummar S, O'Sullivan Coyne G, Do KT, Turkbey B, Meltzer PS, Polley E, Choyke PL, Meehan R, Vilimas R, Horneffer
Y, Juwara L, Lih A, Choudhary A, Mitchell SA, Helman LJ, Doroshow JH, Chen AP. Clinical Activity of the γ-Secretase
Inhibitor PF-03084014 in Adults With DesmoidTumors (Aggressive Fibromatosis). J Clin Oncol. 2017 May
10;35(14):1561-1569.
•Penel N, Le Cesne A, Bui BN, Perol D, Brain EG, Ray-Coquard I, Guillemet C, Chevreau C, Cupissol D, Chabaud S,
Jimenez M, Duffaud F, Piperno-Neumann S, Mignot L, Blay JY. Imatinib for progressive and recurrent aggressive
fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up. Ann Oncol.
2011 Feb;22(2):452-7
•Skapek SX, Anderson JR, Hill DA, Henry D, Spunt SL, Meyer W, Kao S, Hoffer FA, Grier HE, Hawkins DS, Raney RB.
Safety and efficacy of high-dose tamoxifen and sulindac for desmoid tumor in children: results of a Children's Oncology
Group (COG) phase II study. Pediatr Blood Cancer. 2013 Jul;60(7):1108-12
Additional References
![Page 35: Desmoid Tumors: The Nonmalignant Malignancy · R. Lor Randall MD, FACS ... Schwartz HS, Tap WD, Wayne JD, Bergman MA, Scavone J. Soft Tissue Sarcoma, Version 2.2016, ... •Kasper](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fd5e70b2dc6b36ff82d0c2a/html5/thumbnails/35.jpg)
Radiation
•Keus RB, Nout RA, Blay JY, de Jong JM, Hennig I, Saran F, Hartmann JT, Sunyach MP, Gwyther SJ,
Ouali M, Kirkpatrick A, Poortmans PM, Hogendoorn PC, van der Graaf WT. Results of a phase II pilot
study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis--an EORTC STBSG and
ROG study. Ann Oncol. 2013 Oct;24(10):2672-6.
Ultrasound Ablation of Desmoid Tumors
•Bucknor MD, Rieke V.. MRgFUS for desmoid tumors within the thigh: early clinical experiences. J Ther
Ultrasound. 2017 Feb 3;5:4
•Ghanouni P, Dobrotwir A, Bazzocchi A, Bucknor M, Bitton R, Rosenberg J, Telischak K, Busacca M,
Ferrari S, Albisinni U, Walters S, Gold G, Ganjoo K, Napoli A, Pauly KB, Avedian R. Magnetic resonance-
guided focused ultrasound treatment of extra-abdominal desmoidtumors: a retrospective multicenter study.
Eur Radiol. 2017 Feb;27(2):732-740
Biology of Desmoid Tumors•Trang SH, Joyner DE, Damron TA, Aboulafia AJ, Randall RL. Potential for functional redundancy in EGF and TGFalpha signaling in desmoid cells: a cDNA microarray analysis. Growth Factors. 2010 Feb;28(1):10-23.
•Joyner DE, Trang SH, Aboulafia AJ, Damron TA, Randall RL. FAP-associated desmoid invasiveness correlates with in vitro resistance to doxorubicin. Fam Cancer. 2009;8(4):569-80.
•Joyner DE, Trang SH, Damron TA, Aboulafia AJ, Cummings JE, Randall RL. Desmoid cell motility is induced in vitro by rhEGF. J Orthop Res. 2009 Sep;27(9):1258-62
Additional References
![Page 36: Desmoid Tumors: The Nonmalignant Malignancy · R. Lor Randall MD, FACS ... Schwartz HS, Tap WD, Wayne JD, Bergman MA, Scavone J. Soft Tissue Sarcoma, Version 2.2016, ... •Kasper](https://reader036.vdocuments.site/reader036/viewer/2022062605/5fd5e70b2dc6b36ff82d0c2a/html5/thumbnails/36.jpg)
Thanks for your Attention!